Molnupiravir: A Versatile Prodrug against SARS-CoV-2 Variants

The nucleoside analog β-D-N4-hydroxycytidine is the active metabolite of the prodrug molnupiravir and is accepted as an efficient drug against COVID-19. Molnupiravir targets the RNA-dependent RNA polymerase (RdRp) enzyme, which is responsible for replicating the viral genome during the replication p...

Descripción completa

Detalles Bibliográficos
Autores principales: Teli, Divya, Balar, Pankti, Patel, Kishan, Sharma, Anu, Chavda, Vivek, Vora, Lalit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962121/
https://www.ncbi.nlm.nih.gov/pubmed/36837928
http://dx.doi.org/10.3390/metabo13020309

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9962121/
https://www.ncbi.nlm.nih.gov/pubmed/36837928
http://dx.doi.org/10.3390/metabo13020309

Ejemplares similares